Literature DB >> 8415350

Hypomagnesaemia and hypocalcaemia in a patient with ovarian carcinoma.

G P Leese1, R T Jung, M C Browning.   

Abstract

A patient with disseminated ovarian carcinoma presented with symptoms of hypocalcaemia secondary to hypomagnesaemia. The low serum magnesium (0.4 mmol/l) appeared to be due to renal leakage with no evidence of ureteric obstruction or hydronephrosis on intravenous urogram. Parathyroid hormone activity (serum levels and cAMP response) was normal, despite hypomagnesaemia. The patient's complaints resolved after magnesium and calcium supplementation. Hypomagnesaemia of malignancy is a rare but important complication, and is both poorly recognized and understood.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415350      PMCID: PMC2399883          DOI: 10.1136/pgmj.69.813.583

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  9 in total

1.  Metabolic studies in a case of hypocalcemia and osteoblastic metastases.

Authors:  C L Tommaso; J R Tucci
Journal:  Arch Intern Med       Date:  1979-02

Review 2.  Magnesium deficiency.

Authors:  R E Cronin; J P Knochel
Journal:  Adv Intern Med       Date:  1983

Review 3.  Magnesium deficiency and excess.

Authors:  R K Rude; F R Singer
Journal:  Annu Rev Med       Date:  1981       Impact factor: 13.739

4.  Clinical manifestations of hypomagnesemia.

Authors:  M E Kingston; M B Al-Siba'i; W C Skooge
Journal:  Crit Care Med       Date:  1986-11       Impact factor: 7.598

Review 5.  Renal handling of magnesium: drug and hormone interactions.

Authors:  G A Quamme
Journal:  Magnesium       Date:  1986

6.  Magnesium administration reverses the hypocalcaemia secondary to hypomagnesaemia despite low circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxy vitamin D.

Authors:  M Fuss; E Cogan; C Gillet; R Karmali; J Geurts; A Bergans; H Brauman; R Bouillon; J Corvilain
Journal:  Clin Endocrinol (Oxf)       Date:  1985-06       Impact factor: 3.478

7.  Hypocalcemia in patients with prostate cancer.

Authors:  S C Kukreja; A Shanmugam; T E Lad
Journal:  Calcif Tissue Int       Date:  1988-12       Impact factor: 4.333

8.  Predictors of clinical hypomagnesemia. Hypokalemia, hypophosphatemia, hyponatremia, and hypocalcemia.

Authors:  R Whang; T O Oei; J K Aikawa; A Watanabe; J Vannatta; A Fryer; M Markanich
Journal:  Arch Intern Med       Date:  1984-09

9.  Hypocalcemia associated with a calcitonin-producing hepatocellular carcinoma.

Authors:  P J Maguire; J S Macdonald
Journal:  Arch Intern Med       Date:  1981-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.